Raymond James Financial Services Advisors, Inc. Treace Medical Concepts, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$12.93 - $20.29 $284,460 - $446,380	-22,000 Reduced 4.95%	422,785 $6.06 Million
Q1 2022 May 11, 2022	SELL	$16.73 - $21.58 $418,668 - $540,039	-25,025 Reduced 5.33%	444,785 $8.41 Million
Q4 2021 Feb 08, 2022	BUY	$15.48 - $26.52 $7.27 Million - $12.5 Million	469,810 New	469,810 $8.76 Million

Others Institutions Holding TMCI

# of Institutions

141

Shares Held

39.7M

Call Options Held

352K

Put Options Held

269K

Armistice Capital, LLC New York, NY

6.2M
Shares

$65.3 Million
0.6% of portfolio
Black Rock Inc. New York, NY

4.07M
Shares

$42.9 Million
0.0% of portfolio
Morgan Stanley New York, NY

3.27M
Shares

$34.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$28.9 Million
0.0% of portfolio
William Blair Investment Management, LLC Chicago, IL

2.39M
Shares

$25.2 Million
0.04% of portfolio

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $584M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account